Cardiovascular Systems, Inc. (CSII)

NASDAQ: CSII · IEX Real-Time Price · USD
13.68
-1.04 (-7.07%)
Feb 6, 2023, 3:11 PM EST - Market open
-7.07%
Market Cap 572.53M
Revenue (ttm) 237.53M
Net Income (ttm) -38.95M
Shares Out 41.88M
EPS (ttm) -0.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 227,086
Open 14.66
Previous Close 14.72
Day's Range 13.64 - 14.70
52-Week Range 12.26 - 23.47
Beta 0.84
Analysts Buy
Price Target 20.40 (+49.12%)
Earnings Date Feb 9, 2023

About CSII

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Co... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Feb 26, 2009
Employees 725
Stock Exchange NASDAQ
Ticker Symbol CSII
Full Company Profile

Financial Performance

In 2022, CSII's revenue was $236.22 million, a decrease of -8.79% compared to the previous year's $258.97 million. Losses were -$36.93 million, 175.2% more than in 2021.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for CSII stock is "Buy." The 12-month stock price forecast is $20.4, which is an increase of 49.12% from the latest price.

Price Target
$20.4
(49.12% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Cardiovascular Systems (CSII) Global Sales Up, Margin Woe Stays

Cardiovascular Systems (CSII) international revenues are showing strong growth in each of the key markets, including Japan, Europe, Asia Pacific and Canada.

2 weeks ago - Zacks Investment Research

Cardiovascular Systems, Inc. to Host Earnings Conference Call on February 9, 2023

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (NASDAQ: CSII) plans to announce its operating results for the quarter ended December 31, 2022 before the market opens on Thursday, Feb...

2 weeks ago - Business Wire

Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

3 weeks ago - Business Wire

Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.'s Thrombectomy System

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patien...

1 month ago - Business Wire

Cardiovascular Systems (CSII) Q1 Earnings Miss, Revenues Top

The launch of the Scoreflex scoring balloon receives a positive response and generates over $1.7 million in sales during the first quarter for Cardiovascular Systems (CSII).

3 months ago - Zacks Investment Research

Cardiovascular Systems (CSII) Reports Q1 Loss, Tops Revenue Estimates

Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -12.50% and 0.58%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the st...

3 months ago - Zacks Investment Research

Cardiovascular Systems (CSII) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Cardiovascular Systems (CSII) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Why Is Cardiovascular Systems (CSII) Down 18.9% Since Last Earnings Report?

Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

Cardiovascular Systems (CSII) Q4 Earnings, Revenues Miss Mark

According to Cardiovascular Systems (CSII), strong sequential growth in each of its segments is due to procedure recovery, focused commercial strategies and the launch of products.

6 months ago - Zacks Investment Research

Cardiovascular Systems, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results

ST. PAUL, Minn.--(BUSINESS WIRE)--CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2022 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

6 months ago - Business Wire

Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022

7 months ago - Business Wire

Cardiovascular Systems (CSII) Up 0.9% Since Last Earnings Report: Can It Continue?

Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock?

8 months ago - Zacks Investment Research

Cardiovascular Systems' (CSII) Q3 Earnings Top Estimates

Cardiovascular Systems' (CSII) third-quarter revenues declined year over year due to lower Coronary and peripheral revenues.

9 months ago - Zacks Investment Research

Cardiovascular Systems (CSII) Reports Q3 Loss, Lags Revenue Estimates

Cardiovascular Systems (CSII) delivered earnings and revenue surprises of 10.71% and 2%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Cardiovascular Systems, Inc. Reports Fiscal 2022 Third Quarter Financial Results

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients w...

9 months ago - Business Wire

Cardiovascular Systems (CSII) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Cardiovascular Systems (CSII) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

10 months ago - Zacks Investment Research

3 Medical Product Stocks Poised to Beat This Earnings Season

Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.

Other symbols: ABTALCISRGZBH
10 months ago - Zacks Investment Research

Here's Why You Should Hold on to Cardiovascular Systems (CSII)

Investors are optimistic about Cardiovascular Systems' (CSII) robust international growth and upcoming launches.

10 months ago - Zacks Investment Research

Cardiovascular Systems, Inc. to Host Earnings Conference Call on May 4, 2022

ST. PAUL, Minn.--(BUSINESS WIRE)--CARDIOVASCULAR SYSTEMS, INC. TO HOST EARNINGS CONFERENCE CALL ON MAY 4, 2022

10 months ago - Business Wire

Cardiovascular Systems, Inc. to Participate at Two Upcoming Healthcare Conferences

ST. PAUL, Minn.--(BUSINESS WIRE)--CARDIOVASCULAR SYSTEMS, INC. TO PARTICIPATE AT TWO UPCOMING HEALTHCARE CONFERENCES

11 months ago - Business Wire

Cardiovascular Systems, Inc. Announces First In-Human Experience With Company's Propel™ Percutaneous Ventricular Assist Device

ST. PAUL, Minn.--(BUSINESS WIRE)--CARDIOVASCULAR SYSTEMS, INC. ANNOUNCES FIRST IN-HUMAN EXPERIENCE WITH COMPANY'S PROPEL™ PERCUTANEOUS VENTRICULAR ASSIST DEVICE

11 months ago - Business Wire